Shopping Cart
- Remove All
- Your shopping cart is currently empty
4-Phenoxybenzylamine inhibits the function of the NS3 protein by stabilizing an inactive conformation, with an IC50 of approximately 500 μM against HCV NS3/4a.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
200 mg | $30 | In Stock | |
500 mg | $45 | In Stock | |
1 g | $66 | In Stock | |
2 g | $95 | In Stock | |
1 mL x 10 mM (in DMSO) | $29 | In Stock |
Description | 4-Phenoxybenzylamine inhibits the function of the NS3 protein by stabilizing an inactive conformation, with an IC50 of approximately 500 μM against HCV NS3/4a. |
Targets&IC50 | HCV NS3/4A:500 μM |
In vitro | A novel and highly conserved binding site at the interface of the protease and helicase domains of the Hepatitis C Virus (HCV) NS3 protein has been identified. Binding of 4-Phenoxybenzylamine to this allosteric site inhibits NS3 function by stabilizing an inactive conformation, introducing a new class of direct-acting antiviral agents. |
Molecular Weight | 199.25 |
Formula | C13H13NO |
Cas No. | 107622-80-0 |
Smiles | NCC1=CC=C(OC2=CC=CC=C2)C=C1 |
Relative Density. | 1.12 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (150.56 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.